CNW -- Isotechnika Pharma Inc., announced today that three posters were presented by Investigators, in the Phase 3 psoriasis trial (ESSENCE), at the Canadian Dermatology Association’s 84th Annual Conference in Vancouver, BC, July 1 - 5.
CNW -- Isotechnika Pharma Inc., announced today that three posters were presented by Investigators, in the Phase 3 psoriasis trial (ESSENCE), at the Canadian Dermatology Association’s 84th Annual Conference in Vancouver, BC, July 1 - 5.
